CSPC Hunan Jingfeng Pharmaceutical Co., Ltd. (SHE:000908)
China flag China · Delayed Price · Currency is CNY
4.740
-0.070 (-1.46%)
Nov 18, 2026, 3:04 PM CST

SHE:000908 Revenue

CSPC Hunan Jingfeng Pharmaceutical had revenue of 105.25M CNY in the quarter ending September 30, 2026, with 9.66% growth. This brings the company's total for the last twelve months to 406.39M, up 1.42% year-over-year. In the year 2025, CSPC Hunan Jingfeng Pharmaceutical had annual revenue of 378.11M, down -9.11%. That makes CSPC Hunan Jingfeng Pharmaceutical the 26,528th largest company in the world by revenue and 4,638th in China.

Revenue (ttm)
406.39M
Revenue Growth
+1.42%
P/S Ratio
20.83
Revenue / Employee
877.73K
Employees
463
Market Cap
8.34B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceuticals 363.70M 96.2%
  • Others 14.42M 3.8%

By Geography

Chart
  • North China 120.00M 31.7%
  • East China 107.37M 28.4%
  • Southwest 46.39M 12.3%
  • Central China 41.67M 11.0%
  • Northeast 32.95M 8.7%
  • Northwest 12.60M 3.3%
  • Export 8.83M 2.3%
  • South China 8.31M 2.2%
Fiscal year ended Dec 31, 2025 See the full SHE:000908 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025378.11M-37.92M-9.11%
Dec 31, 2024416.03M-240.86M-36.67%
Dec 31, 2023656.89M-183.76M-21.86%
Jan 1, 2023840.66M29.47M3.63%
Jan 1, 2022811.18M-66.74M-7.60%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.